BREAKING: Elab Supports NCPC Aino in Achieving Zero-Defect FDA Inspection!

NCPC Aino Successfully Passes 2025 FDA On-Site Audit with Elab's Expert Support

NCPC Aino has successfully passed the U.S. FDA on-site inspection from March 10 to 14, 2025 with the comprehensive guidance of our company, marking another solid step forward in its internationalization journey! The FDA inspection is renowned as the "strictest test" in the global pharmaceutical industry, and its rigor speaks for itself.

For NCPC Aino, this was not only a comprehensive examination of its quality management system but also a profound refinement of its international capabilities. Throughout this process, our company, as a professional pharmaceutical consulting and service provider, delivered all-round guidance and support with our extensive experience and expert team.